NPD4456

CAS No. 859668-98-7

NPD4456( NPD-4456 | NPD 4456 )

Catalog No. M16229 CAS No. 859668-98-7

A coumarin-based HIV-1 viral protein R (Vpr) inhibitor, inhibits Vpr-dependent viral infection of human macrophages.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NPD4456
  • Note
    Research use only, not for human use.
  • Brief Description
    A coumarin-based HIV-1 viral protein R (Vpr) inhibitor, inhibits Vpr-dependent viral infection of human macrophages.
  • Description
    A coumarin-based HIV-1 viral protein R (Vpr) inhibitor, inhibits Vpr-dependent viral infection of human macrophages.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NPD-4456 | NPD 4456
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    859668-98-7
  • Formula Weight
    383.39
  • Molecular Formula
    C21H21NO6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=C(C(=O)OC2=C1C=CC(=C2)OC(=O)N(C)C)C3=C(C=CC(=C3)OC)OC
  • Chemical Name
    Dimethyl-carbamic acid 3-(2,5-dimethoxyphenyl)-4-methyl-2-oxo-2H-1-benzopyran-7-yl ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ong EB, et al. J Biol Chem. 2011 Apr 22;286(16):14049-56.
molnova catalog
related products
  • GSK-364735

    GSK-364735 is a human immunodeficiency virus type 1 integrase (HIV-1 IN) inhibitor with antiviral activity and is used in the study of retroviral infections.

  • BMS-986001

    A thymidine analogue nucleoside reverse transcriptase inhibitor (NRTI) that inhibits HIV-2 isolates from treatment-naive individuals with EC50 of 30-81 nM.

  • (Iso)-Fosdevirine

    (Iso)-Fosdevirine ( (Iso)-GSK2248761) is a selective and potent non-nucleoside reverse transcriptase (NNRTI) inhibitor with anti-HIV activity for the study of neurological disorders such as late-onset epilepsy.